Anand Kapila K 4

What Happened Anand Kapila K, a non-employee director of Elanco Animal Health Inc. (ELAN), was granted a total of 16,874 equity units on May 21, 2026 — 4,678 deferred stock units and 12,196 restricted stock units. Each grant is reported at $0.00 per share because these are awards (not purchases) and no cash changed hands at grant. These awards are compensation, not open-market purchases or sales.

Key Details

• Transaction date: 2026-05-21; Filing date: 2026-05-26 (timely filed).
• Grants: 4,678 deferred stock units (F1) and 12,196 restricted stock units (F2); total = 16,874 units.
• Reported price: $0.00 (award/grant).
• Shares owned after transaction: not specified in the provided filing summary.
• Footnotes: F1 = pro‑rated deferred stock units as annual equity award for non-employee board members; F2 = restricted stock units as annual equity award for non-employee board members.
• Filing status: No late filing indicated.

Context These are director compensation awards common for non-employee board members. Deferred stock units typically convert to cash or stock upon separation/retirement per plan terms; restricted stock units generally vest over time per the award agreement. Because these are grants (not purchases or sales), they reflect compensation practices and not an open‑market investment signal.